Personal information

Emails & domains

Verified email addresses

Verified email domains

Other IDs

Scopus Author ID: 24577958200
ResearcherID: C-6113-2013

Countries

Poland

Activities

Collapse all

Employment (5)

Jagiellonian University: Krakow, PL

2022-09-02 to present | Group leader (Bioorganic and Medicinal Chemistry Group, Department of Organic Chemistry, Faculty of Chemistry)
Employment
Source: Self-asserted source
Lukasz Skalniak

Jagiellonian University: Krakow, PL

2013-08-01 to 2022-09-01 (Chemical Biology and Drug Design Group, Faculty of Chemistry)
Employment
Source: Self-asserted source
Lukasz Skalniak

Jagiellonian University: Krakow, PL

2012-03 to 2013-06 | Scientific Assistant (General Biochemistry Department, Faculty of Biochemistry, Biophysics and Biotechnology)
Employment
Source: Self-asserted source
Lukasz Skalniak

Jagiellonian University: Krakow, PL

2008-02 to 2009-09 (Cell Biochemistry Department, Faculty of Biochemistry, Biophysics and Biotechnology)
Employment
Source: Self-asserted source
Lukasz Skalniak

Technical University of Munich: Munich, DE

2007-02 to 2007-07 | Scientific Assistant ( Chair of Biotechnology, TUM School of Natural Sciences )
Employment
Source: Self-asserted source
Lukasz Skalniak

Education and qualifications (3)

Jagiellonian University: Krakow, PL

2022-12-15 | Post-doctoral degree (habilitation) in the field of Chemistry (Faculty of Chemistry, Jagiellonian University, Krakow, Poland)
Education
Source: Self-asserted source
Lukasz Skalniak

Jagiellonian University: Krakow, PL

2013-06-25 | Ph.D. degree in the field of Biochemistry (Faculty of Biochemistry, Biophysics and Biotechnology)
Education
Source: Self-asserted source
Lukasz Skalniak

Jagiellonian University: Krakow, PL

2008-06-17 | M.Sc. degree in the field of Biotechnology (Faculty of Biochemistry, Biophysics and Biotechnology)
Education
Source: Self-asserted source
Lukasz Skalniak

Professional activities (2)

American Association for Cancer Research: Philadelphia, PA, US

2019-02-21 to present | Active Membership
Membership
Source: Self-asserted source
Lukasz Skalniak

European Association For Cancer Research: Nottingham, Nottingham, GB

2018-02-06 to present | Member
Membership
Source: Self-asserted source
Lukasz Skalniak

Funding (3)

Photoswitchable and chimeric molecules for spatially restricted and endoplasmic reticulum-specific blockade of PD-L1 protein

2022-04 to 2027-04 | Grant
National Science Center (Krakow, PL)
URL: https://projekty.ncn.gov.pl/en/index.php?projekt_id=529850
GRANT_NUMBER:

UMO-2021/42/E/NZ7/00422
Source: Self-asserted source
Lukasz Skalniak

Characterization and improvement of anti-cancer properties of second generation antagonists of Mdm2 oncoprotein

2017-02 to 2020-02 | Grant
National Science Center (Krakow, PL)
URL: https://projekty.ncn.gov.pl/en/index.php?projekt_id=334861
GRANT_NUMBER:

UMO-2016/21/D/NZ7/00596
Source: Self-asserted source
Lukasz Skalniak
grade
Preferred source (of 2)‎

The role of proteolytic cleavage in molecular functions fulfilled by MCPIP

2012-09 to 2014-09 | Grant
National Science Center (Krakow, PL)
URL: https://projekty.ncn.gov.pl/en/index.php?projekt_id=169735
GRANT_NUMBER:

UMO-2011/03/N/NZ1/01193
Source: Self-asserted source
Lukasz Skalniak
grade
Preferred source (of 2)‎

Works (50 of 52)

Items per page:
Page 1 of 2

N-methylmorpholine incorporation into the structure of biphenyl leads to the bioactive inhibitor of PD-1/PD-L1 interaction

Bioorganic & Medicinal Chemistry Letters
2024-09 | Journal article
DOI: 10.1016/j.bmcl.2024.129882
Contributors: Julia Zaber; Lukasz Skalniak; Ganna P. Gudz; Aleksandra Hec-Gałązka; Magdalena Zarnik; Urszula Tyrcha; Malgorzata Stec; Maciej Siedlar; Tad A. Holak; Tomasz Sitar et al.
Source: check_circle
Crossref

An updated patent review on PD-1/PD-L1 antagonists (2022-present)

Expert Opinion on Therapeutic Patents
2024-08-02 | Journal article
DOI: 10.1080/13543776.2024.2368237
Contributors: Wiktor Uzar; Beata Kaminska; Hubert Rybka; Lukasz Skalniak; Katarzyna Magiera-Mularz; Radoslaw Kitel
Source: check_circle
Crossref

C2-Symmetrical Terphenyl Derivatives as Small Molecule Inhibitors of Programmed Cell Death 1/Programmed Death Ligand 1 Protein–Protein Interaction

Molecules
2024-06 | Journal article | Author
DOI: 10.3390/molecules29112646
Contributors: Joanna Klimek; Oskar Kruc; Joanna Ceklarz; Beata Kamińska; Bogdan Musielak; Robin van der Straat; Alexander Domling; Tad A. Holak; Damian Muszak; Justyna Kalinowska-Tłuścik et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Structural and biological characterization of pAC65, a macrocyclic peptide that blocks PD-L1 with equivalent potency to the FDA-approved antibodies

Molecular Cancer
2023-09-07 | Journal article
DOI: 10.1186/s12943-023-01853-4
Part of ISSN: 1476-4598
Contributors: Ismael Rodriguez; Justyna Kocik-Krol; Lukasz Skalniak; Bogdan Musielak; Aneta Wisniewska; Agnieszka Ciesiołkiewicz; Łukasz Berlicki; Jacek Plewka; Przemyslaw Grudnik; Malgorzata Stec et al.
Source: Self-asserted source
Lukasz Skalniak

Design, Synthesis, and Biological Evaluation of 2-Hydroxy-4-phenylthiophene-3-carbonitrile as PD-L1 Antagonist and Its Comparison to Available Small Molecular PD-L1 Inhibitors

Journal of Medicinal Chemistry
2023-07-27 | Journal article
DOI: 10.1021/acs.jmedchem.3c00254
Part of ISSN: 0022-2623
Part of ISSN: 1520-4804
Contributors: Marta Ważyńska; Roberto Butera; Marta Requesens; Annechien Plat; Tryfon Zarganes-Tzitzikas; Constantinos Neochoritis; Jacek Plewka; Lukasz Skalniak; Justyna Kocik-Krol; Bogdan Musielak et al.
Source: Self-asserted source
Lukasz Skalniak

A study of the interactions between human osteoblast-like cells and polymer composites with functionalized graphene derivatives using 2D correlation spectroscopy (2D-COS)

Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
2023-01 | Journal article
DOI: 10.1016/j.saa.2022.121862
Part of ISSN: 1386-1425
Contributors: Anna Kołodziej; Aleksandra Wesełucha-Birczyńska; Elżbieta Długoń; Małgorzata Świętek; Maciej Gubernat; Łukasz Skalniak; Marta Błażewicz
Source: Self-asserted source
Lukasz Skalniak

Biphenyl Ether Analogs Containing Pomalidomide as Small-Molecule Inhibitors of the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction

Molecules
2022-05 | Journal article | Author
DOI: 10.3390/molecules27113454
Contributors: Shabnam Shaabani; Louis Gadina; Ewa Surmiak; Zefeng Wang; Bidong Zhang; Roberto Butera; Tryfon Zarganes-Tzitzikas; Ismael Rodríguez; Justyna Kocik-Krol; Katarzyna Magiera-Mularz et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Application of bioorthogonal hetero-Diels–Alder cycloaddition of 5-arylidene derivatives of 1,3-dimethylbarbituric acid and vinyl thioether for imaging inside living cells

Organic & Biomolecular Chemistry
2021 | Journal article
DOI: 10.1039/D1OB00697E
Contributors: Bartłomiej Bazan; Aleksandra Pałasz; Łukasz Skalniak; Dariusz Cież; Szymon Buda; Katarzyna Jędrzejowska; Sonia Głomb; Daniel Kamzol; Kinga Czarnota; Krystian Latos et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Human and mouse PD-L1: similar molecular structure, but different druggability profiles

iScience
2021 | Journal article
DOI: 10.1016/j.isci.2020.101960
EID:

2-s2.0-85098659116

Part of ISSN: 25890042
Contributors: Magiera-Mularz, K.; Kocik, J.; Musielak, B.; Plewka, J.; Sala, D.; Machula, M.; Grudnik, P.; Hajduk, M.; Czepiel, M.; Siedlar, M. et al.
Source: Self-asserted source
Lukasz Skalniak via Scopus - Elsevier

Macrocyclic Peptide Inhibitor of PD-1/PD-L1 Immune Checkpoint

Advanced Therapeutics
2021 | Journal article
DOI: 10.1002/adtp.202000195
EID:

2-s2.0-85103745010

Part of ISSN: 23663987
Contributors: Magiera-Mularz, K.; Kuska, K.; Skalniak, L.; Grudnik, P.; Musielak, B.; Plewka, J.; Kocik, J.; Stec, M.; Weglarczyk, K.; Sala, D. et al.
Source: Self-asserted source
Lukasz Skalniak via Scopus - Elsevier

Terphenyl-Based Small-Molecule Inhibitors of Programmed Cell Death-1/Programmed Death-Ligand 1 Protein-Protein Interaction

Journal of Medicinal Chemistry
2021 | Journal article
DOI: 10.1021/acs.jmedchem.1c00957
EID:

2-s2.0-85112721108

Part of ISSN: 15204804 00222623
Contributors: Muszak, D.; Surmiak, E.; Plewka, J.; Magiera-Mularz, K.; Kocik-Krol, J.; Musielak, B.; Sala, D.; Kitel, R.; Stec, M.; Weglarczyk, K. et al.
Source: Self-asserted source
Lukasz Skalniak via Scopus - Elsevier

Terphenyl-based small-molecule inhibitors of programmed cell death-1/programmed death-ligand 1 protein−protein interaction

ChemRxiv
2021 | Other
DOI: 10.26434/chemrxiv.13849442
EID:

2-s2.0-85102671028

Part of ISSN: 25732293
Contributors: Muszak, D.; Surmiak, E.; Plewka, J.; Magiera-Mularz, K.; Kocik, J.; Musielak, B.; Sala, D.; Kitel, R.; Stec, M.; Siedlar, M. et al.
Source: Self-asserted source
Lukasz Skalniak via Scopus - Elsevier

PD-L1 Inhibitors: Different Classes, Activities, and Mechanisms of Action

International Journal of Molecular Sciences
2021-10 | Journal article | Author
DOI: 10.3390/ijms222111797
Contributors: Ewa Surmiak; Katarzyna Magiera-Mularz; Bogdan Musielak; Damian Muszak; Justyna Kocik-Krol; Radoslaw Kitel; Jacek Plewka; Tad A. Holak; Lukasz Skalniak
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 4)‎

Early Recognition of the PCL/Fibrous Carbon Nanocomposites Interaction with Osteoblast-like Cells by Raman Spectroscopy

Nanomaterials
2021-10-28 | Journal article
DOI: 10.3390/nano11112890
Contributors: Aleksandra Wesełucha-Birczyńska; Anna Kołodziej; Małgorzata Świętek; Łukasz Skalniak; Elżbieta Długoń; Maria Pajda; Marta Błażewicz
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

Germacranolides from Carpesium divaricatum: Some New Data on Cytotoxic and Anti-Inflammatory Activity

Molecules
2021-07-30 | Journal article
DOI: 10.3390/molecules26154644
Contributors: Natalia Kłeczek; Janusz Malarz; Barbara Gierlikowska; Łukasz Skalniak; Agnieszka Galanty; Anna K. Kiss; Anna Stojakowska
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

A 2D-Raman correlation spectroscopy study of the interaction of the polymer nanocomposites with carbon nanotubes and human osteoblast-like cells interface

Journal of Molecular Structure
2020 | Journal article
DOI: 10.1016/j.molstruc.2020.128135
EID:

2-s2.0-85082864095

Part of ISSN: 00222860
Contributors: Kołodziej, A.; Wesełucha-Birczyńska, A.; Świętek, M.; Skalniak; Błażewicz, M.
Source: Self-asserted source
Lukasz Skalniak via Scopus - Elsevier

Anti-CD44 DNA Aptamers Selectively Target Cancer Cells

Nucleic Acid Therapeutics
2020 | Journal article
DOI: 10.1089/nat.2019.0833
EID:

2-s2.0-85092945507

Part of ISSN: 21593345 21593337
Contributors: Pȩcak, A.; Skalniak, L.; Pels, K.; Ksiek, M.; Madej, M.; Krzemień, D.; Malicki, S.; Władyka, B.; Dubin, A.; Holak, T.A. et al.
Source: Self-asserted source
Lukasz Skalniak via Scopus - Elsevier

Does 2D correlation Raman spectroscopy distinguish polymer nanomaterials due to the nanoaddition?

Journal of Molecular Structure
2020 | Journal article
DOI: 10.1016/j.molstruc.2020.128342
EID:

2-s2.0-85084309646

Part of ISSN: 00222860
Contributors: Wesełucha-Birczyńska, A.; Kołodziej, A.; Świętek, M.; Moskal, P.; Skalniak, Ł.; Długoń, E.; Błażewicz, M.
Source: Self-asserted source
Lukasz Skalniak via Scopus - Elsevier

Multicomponent Peptide Stapling as a Diversity-Driven Tool for the Development of Inhibitors of Protein–Protein Interactions

Angewandte Chemie - International Edition
2020 | Journal article
DOI: 10.1002/anie.201916257
EID:

2-s2.0-85079237995

Part of ISSN: 15213773 14337851
Contributors: Ricardo, M.G.; Ali, A.M.; Plewka, J.; Surmiak, E.; Labuzek, B.; Neochoritis, C.G.; Atmaj, J.; Skalniak, L.; Zhang, R.; Holak, T.A. et al.
Source: Self-asserted source
Lukasz Skalniak via Scopus - Elsevier

Systematic ‘foldamerization’ of peptide inhibiting p53-MDM2/X interactions by the incorporation of trans- or cis-2-aminocyclopentanecarboxylic acid residues

European Journal of Medicinal Chemistry
2020 | Journal article
DOI: 10.1016/j.ejmech.2020.112814
EID:

2-s2.0-85091511324

Part of ISSN: 17683254 02235234
Contributors: Fortuna, P.; Twarda-Clapa, A.; Skalniak, L.; Ożga, K.; Holak, T.A.; Berlicki
Source: Self-asserted source
Lukasz Skalniak via Scopus - Elsevier

Resveratrol enhances apoptosis induced by the heterocyclic aromatic amines in p53-wt LoVo cells, but not in p53-deficient HaCaT cells

Acta Biochimica Polonica
2020-10-27 | Journal article
DOI: 10.18388/abp.2020_5477
Contributors: Katarzyna Kuryłowicz; Agnieszka Cierniak; Ewelina Madej; Łukasz Skalniak; Agnieszka Wolnicka-Głubisz
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Di-bromo-Based Small-Molecule Inhibitors of the PD-1/PD-L1 Immune Checkpoint

Journal of Medicinal Chemistry
2020-10-08 | Journal article
DOI: 10.1021/acs.jmedchem.0c01260
Contributors: Magdalena Konieczny; Bogdan Musielak; Justyna Kocik; Lukasz Skalniak; Dominik Sala; Miroslawa Czub; Katarzyna Magiera-Mularz; Ismael Rodriguez; Maja Myrcha; Malgorzata Stec et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Hitting on the move: Targeting intrinsically disordered protein states of the MDM2-p53 interaction

European Journal of Medicinal Chemistry
2019 | Journal article
DOI: 10.1016/j.ejmech.2019.111588
EID:

2-s2.0-85070651334

Part of ISSN: 17683254 02235234
Contributors: Neochoritis, C.G.; Atmaj, J.; Twarda-Clapa, A.; Surmiak, E.; Skalniak, L.; Köhler, L.-M.; Muszak, D.; Kurpiewska, K.; Kalinowska-Tłuścik, J.; Beck, B. et al.
Source: Self-asserted source
Lukasz Skalniak via Scopus - Elsevier

Raman microspectroscopic investigations of polymer nanocomposites: evaluation of physical and biophysical properties

International Journal of Polymeric Materials and Polymeric Biomaterials
2019 | Journal article
DOI: 10.1080/00914037.2018.1525722
EID:

2-s2.0-85059332820

Part of ISSN: 1563535X 00914037
Contributors: Kołodziej, A.; Wesełucha-Birczyńska, A.; Świętek, M.; Skalniak, Ł.; Błażewicz, M.
Source: Self-asserted source
Lukasz Skalniak via Scopus - Elsevier

Design, Synthesis, Evaluation, and Structural Studies of C2-Symmetric Small Molecule Inhibitors of Programmed Cell Death-1/Programmed Death-Ligand 1 Protein–Protein Interaction

Journal of Medicinal Chemistry
2019-08-08 | Journal article
DOI: 10.1021/acs.jmedchem.9b00795
Contributors: Subhadwip Basu; Jeffrey Yang; Bin Xu; Katarzyna Magiera-Mularz; Lukasz Skalniak; Bogdan Musielak; Vladyslav Kholodovych; Tad A. Holak; Longqin Hu
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

CA-170 – A Potent Small-Molecule PD-L1 Inhibitor or Not?

Molecules
2019-08-01 | Journal article
DOI: 10.3390/molecules24152804
Contributors: Bogdan Musielak; Justyna Kocik; Lukasz Skalniak; Katarzyna Magiera-Mularz; Dominik Sala; Miroslawa Czub; Malgorzata Stec; Maciej Siedlar; Tad A. Holak; Jacek Plewka
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

Helping the Released Guardian: Drug Combinations for Supporting the Anticancer Activity of HDM2 (MDM2) Antagonists

Cancers
2019-07-19 | Journal article
DOI: 10.3390/cancers11071014
Contributors: Justyna Kocik; Monika Machula; Aneta Wisniewska; Ewa Surmiak; Tad A. Holak; Lukasz Skalniak
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

CA-170 – a potent small-molecule PD-L1 inhibitor or not?

2019-06-06 | Other
DOI: 10.1101/662668
Contributors: Bogdan Musielak; Justyna Kocik; Lukasz Skalniak; Katarzyna Magiera-Mularz; Dominik Sala; Mirosława Czub; Tad A. Holak; Jacek Plewka
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

A fluorinated indole‐based MDM2 antagonist selectively inhibits the growth of p53wt osteosarcoma cells

The FEBS Journal
2019-04 | Journal article
DOI: 10.1111/febs.14774
Contributors: Lukasz Skalniak; Aleksandra Twarda‐Clapa; Constantinos G. Neochoritis; Ewa Surmiak; Monika Machula; Aneta Wisniewska; Beata Labuzek; Ameena M. Ali; Sylwia Krzanik; Grzegorz Dubin et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

A therapeutic patent overview of MDM2/X-targeted therapies (2014–2018)

Expert Opinion on Therapeutic Patents
2019-03-04 | Journal article
DOI: 10.1080/13543776.2019.1582645
Contributors: Lukasz Skalniak; Ewa Surmiak; Tad A. Holak
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Identification of small-molecule inhibitors of USP2a

European Journal of Medicinal Chemistry
2018 | Journal article
DOI: 10.1016/j.ejmech.2018.03.009
EID:

2-s2.0-85043358576

Part of ISSN: 17683254 02235234
Contributors: Tomala, M.D.; Magiera-Mularz, K.; Kubica, K.; Krzanik, S.; Zieba, B.; Musielak, B.; Pustula, M.; Popowicz, G.M.; Sattler, M.; Dubin, G. et al.
Source: Self-asserted source
Lukasz Skalniak via Scopus - Elsevier

p38 but not p53 is responsible for UVA-induced MCPIP1 expression

Mechanisms of Ageing and Development
2018 | Journal article
DOI: 10.1016/j.mad.2017.11.008
EID:

2-s2.0-85033802106

Part of ISSN: 18726216 00476374
Contributors: Skalniak, L.; Smejda, M.; Cierniak, A.; Adamczyk, A.; Konieczny, P.; Madej, E.; Wolnicka-Glubisz, A.
Source: Self-asserted source
Lukasz Skalniak via Scopus - Elsevier

Prolonged Idasanutlin (RG7388) Treatment Leads to the Generation of p53-Mutated Cells

Cancers
2018-10 | Journal article | Author
DOI: 10.3390/cancers10110396
Contributors: Lukasz Skalniak; Justyna Kocik-Krol; Justyna Polak; Anna Skalniak; Monika Rak; Agnieszka Wolnicka-Glubisz; Tad A. Holak
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 3)‎

1,4,5-Trisubstituted Imidazole-Based p53-MDM2/MDMX Antagonists with Aliphatic Linkers for Conjugation with Biological Carriers

Journal of Medicinal Chemistry
2017 | Journal article
DOI: 10.1021/acs.jmedchem.7b00104
WOSUID:

WOS:000402498200009
Contributors: Twarda-Clapa, Aleksandra; Krzanik, Sylwia; Kubica, Katarzyna; Guzik, Katarzyna; Labuzek, Beata; Neochoritis, Constantinos G.; Khoury, Kareem; Kowalska, Kaja; Czub, Miroslawa; Dubin, Grzegorz et al.
Source: Self-asserted source
Lukasz Skalniak via ResearcherID
grade
Preferred source (of 3)‎

Bioactive Macrocyclic Inhibitors of the PD-1/PD-L1 Immune Checkpoint

Angewandte Chemie - International Edition
2017 | Journal article
DOI: 10.1002/anie.201707707
EID:

2-s2.0-85031743424

Part of ISSN: 15213773 14337851
Contributors: Magiera-Mularz, K.; Skalniak, L.; Zak, K.M.; Musielak, B.; Rudzinska-Szostak, E.; Berlicki, Ł.; Kocik, J.; Grudnik, P.; Sala, D.; Zarganes-Tzitzikas, T. et al.
Source: Self-asserted source
Lukasz Skalniak via Scopus - Elsevier

Lithocholic Acid Hydroxyamide Destabilizes Cyclin D1 and Induces G(0)/G(1) Arrest by Inhibiting Deubiquitinase USP2a

Cell Chemical Biology
2017 | Journal article
DOI: 10.1016/j.chembiol.2017.03.002
WOSUID:

WOS:000400007300006
Contributors: Magiera, Katarzyna; Tomala, Marcin; Kubica, Katarzyna; De Cesare, Virginia; Trost, Matthias; Zieba, Bartosz J.; Kachamakova-Trojanowska, Neli; Les, Marcin; Dubin, Grzegorz; Holak, Tad A. et al.
Source: Self-asserted source
Lukasz Skalniak via ResearcherID
grade
Preferred source (of 2)‎

MCPIP1 contributes to the inflammatory response of UVB-treated keratinocytes

Journal of Dermatological Science
2017 | Journal article
DOI: 10.1016/j.jdermsci.2017.03.013
WOSUID:

WOS:000406893200003
Contributors: Bugara, Beata; Konieczny, Piotr; Wolnicka-Glubisz, Agnieszka; Eckhar, Leopold; Fischer, Heinz; Skalniak, Lukasz; Borowczyk-Michalowska, Julia; Drukala, Justyna; Jura, Jolanta
Source: Self-asserted source
Lukasz Skalniak via ResearcherID
grade
Preferred source (of 2)‎

Small-molecule inhibitors of PD-1/PD-L1 immune checkpoint alleviate the PD-L1-induced exhaustion of T-cells

Oncotarget
2017 | Journal article
DOI: 10.18632/oncotarget.20050
Source: Self-asserted source
Lukasz Skalniak

Small-Molecule Inhibitors of the Programmed Cell Death-1/Programmed Death-Ligand 1 (PD-1/PD-L1) Interaction via Transiently Induced Protein States and Dimerization of PD-L1

Journal of Medicinal Chemistry
2017 | Journal article
DOI: 10.1021/acs.jmedchem.7b00293
WOSUID:

WOS:000405764900039
Contributors: Guzik, Katarzyna; Zak, Krzysztof M.; Grudnik, Przemyslaw; Magiera, Katarzyna; Musielak, Bogdan; Torner, Ricarda; Skalniak, Lukasz; Domling, Alexander; Dubin, Grzegorz; Holak, Tad A.
Source: Self-asserted source
Lukasz Skalniak via ResearcherID
grade
Preferred source (of 3)‎

MCPIP1 contributes to the toxicity of proteasome inhibitor MG-132 in HeLa cells by the inhibition of NF-κB

Molecular and Cellular Biochemistry
2014 | Journal article
DOI: 10.1007/s11010-014-2134-z
EID:

2-s2.0-84940277451
Contributors: Skalniak, L.; Dziendziel, M.; Jura, J.
Source: Self-asserted source
Lukasz Skalniak via Scopus - Elsevier
grade
Preferred source (of 2)‎

Effect of silver nanoparticles on human primary keratinocytes

Biological Chemistry
2013 | Journal article
DOI: 10.1515/hsz-2012-0202
EID:

2-s2.0-84876574800
Contributors: Jura, J.; Szmyd, R.; Goralczyk, A.G.; Skalniak, L.; Cierniak, A.; Lipert, B.; Filon, F.L.; Crosera, M.; Borowczyk, J.; Laczna, E. et al.
Source: Self-asserted source
Lukasz Skalniak via Scopus - Elsevier
grade
Preferred source (of 2)‎

Effects triggered by platinum nanoparticles on primary keratinocytes

International Journal of Nanomedicine
2013 | Journal article
DOI: 10.2147/IJN.S49612
EID:

2-s2.0-84885826883
Contributors: Konieczny, P.; Goralczyk, A.G.; Szmyd, R.; Skalniak, L.; Koziel, J.; Filon, F.L.; Crosera, M.; Cierniak, A.; Zuba-Surma, E.K.; Borowczyk, J. et al.
Source: Self-asserted source
Lukasz Skalniak via Scopus - Elsevier
grade
Preferred source (of 2)‎

Limited GADD45 alpha expression and function in IL-1 beta toxicity towards insulin-producing cells

Acta Biochimica Polonica
2013 | Journal article
WOSUID:

WOS:000329557400014
Contributors: Skalniak, Lukasz; Gurgul-Convey, Ewa; Okreglicka, Katarzyna; Skalniak, Anna; Jura, Jolanta
Source: Self-asserted source
Lukasz Skalniak via ResearcherID

Limited GADD45α expression and function in IL-1β toxicity towards insulin-producing cells

Acta Biochimica Polonica
2013 | Journal article
EID:

2-s2.0-84893381921
Contributors: Skalniak, L.; Gurgul-Convey, E.; Okreglicka, K.; Skalniak, A.; Jura, J.
Source: Self-asserted source
Lukasz Skalniak via Scopus - Elsevier

Metastases inhibition and cellular damage in melanoma cells irradiated with proton beam

Acta Ophthalmologica
2013 | Journal article
DOI: 10.1111/j.1755-3768.2013.S093.x
WOSUID:

WOS:000336552300168
Contributors: Dixon, B. Romanowska; Kedracka-Krok, S.; Skalniak, L.; Jura, J.; Zuba-Suma, E.; Jasinska, K.; Pawlak, A.; Sowa, U.; Olk, P.; Urbanska, K. et al.
Source: Self-asserted source
Lukasz Skalniak via ResearcherID

Proteasome inhibitor MG-132 induces MCPIP1 expression

FEBS Journal
2013 | Journal article
DOI: 10.1111/febs.12264
EID:

2-s2.0-84878249136
Contributors: Skalniak, L.; Koj, A.; Jura, J.
Source: Self-asserted source
Lukasz Skalniak via Scopus - Elsevier
grade
Preferred source (of 2)‎

Deleterious effect of silver nanoparticles on human primary keratinocytes

Experimental Dermatology
2012 | Journal article
WOSUID:

WOS:000307883900033
Contributors: Szmyd, R.; Goralczyk, A.; Skalniak, L.; Cierniak, A.; Lipert, B.; Filon, F. Larese; Crosera, M.; Borowczyk, J.; Laczna, E.; Drukala, J. et al.
Source: Self-asserted source
Lukasz Skalniak via ResearcherID

Effects of the novel mitochondrial protein mimitin in insulin-secreting cells

Biochemical Journal
2012 | Journal article
DOI: 10.1042/BJ20111920
EID:

2-s2.0-84864364831
Contributors: Hanzelka, K.; Skalniak, L.; Jura, J.; Lenzen, S.; Gurgul-Convey, E.
Source: Self-asserted source
Lukasz Skalniak via Scopus - Elsevier
grade
Preferred source (of 2)‎

MCPIP1: regulating the regulator

Febs Journal
2012 | Journal article
WOSUID:

WOS:000308128602406
Contributors: Skalniak, L.; Dziendziel, M.; Lipert, B.; Plesnar, E.; Mak, P.; Kliza, K.; Wojtowicz, E.; Benedyk, M.; Chalastanis, A.; Mizgalska, D. et al.
Source: Self-asserted source
Lukasz Skalniak via ResearcherID

Monocyte chemotactic protein-1-induced protein-1 (MCPIP1) is a novel multifunctional modulator of inflammatory reactions

Biochimica et Biophysica Acta - Molecular Cell Research
2012 | Journal article
DOI: 10.1016/j.bbamcr.2012.06.029
EID:

2-s2.0-84864818117
Contributors: Jura, J.; Skalniak, L.; Koj, A.
Source: Self-asserted source
Lukasz Skalniak via Scopus - Elsevier
grade
Preferred source (of 2)‎
Items per page:
Page 1 of 2

Peer review (29 reviews for 9 publications/grants)

Review activity for Biomedicine & pharmacotherapy. (2)
Review activity for Bioorganic & medicinal chemistry. (1)
Review activity for Bioorganic chemistry. (3)
Review activity for Communications biology. (1)
Review activity for European journal of medicinal chemistry. (1)
Review activity for Journal of medicinal chemistry. (18)
Review activity for Journal of molecular structure. (1)
Review activity for Medicinal chemistry research. (1)
Review activity for npj precision oncology. (1)
How many people are using ORCID?